VICA - Rafina Innovations Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1070
0.0000 (0.00%)
At close: 1:50PM EDT
Stock chart is not supported by your current browser
Previous Close0.1070
Open0.1070
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1070 - 0.1070
52 Week Range0.0815 - 2.0000
Volume18,750
Avg. Volume5,781
Market Cap1.849M
Beta (3Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)-0.3960
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire4 months ago

    Rafina Innovations Inc Comments on Recent Stock Volume and Price Increase

    GLASGOW, SCOTLAND, Feb. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc has been advised of a significant increase in the share price and trading volume of the Company's shares beginning Monday February 25, 2019. The Company has been advised by OTC Markets Group that the Company is the subject of a promotional campaign by newsletter writers. The material being distributed contains promotional language pertaining to the Company's business, activities and future share price.

  • GlobeNewswire4 months ago

    Rafina Innovations Develops a Prototype Named Flexi Cuff for Deep Vein Thrombosis Patients

    GLASGOW, SCOTLAND, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. ("the Company" (OTCQB: VICA)) is pleased to announce that it has developed a product prototype to assist patients with Deep Vein Thrombosis. Deep Vein Thrombosis (“DVT”) occurs when blood clots form inside veins deep inside the body. Constantinos Zertalis, Rafina’s Chairman, President and CEO, commented: "I am very excited to have this operational prototype ready for the next steps, including discussions with third parties for possible commercialization.

  • ACCESSWIRE4 months ago

    Rafina Innovations Inc., Insider Buying, Share Consolidation and Recent News Could Put this one on Traders Radars

    NEW YORK, NY / ACCESSWIRE / February 25, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Rafina Innovations Inc. (VICA). Rafina Innovations operates two wholly owned subsidiaries in Glasgow UK. Recent changes to Rafina share structure, Insider buying and more in this full report READ MORE.

  • GlobeNewswire4 months ago

    Rafina Innovations Begins Development on a Prototype for Sleep Apnoea

    Constantinos Zertalis, Rafina’s Chairman, President and CEO, commented: "Our research shows that 1 in 6 people suffer from respiratory failure that requires a biPAP machine. Following investigation into the marketspace and needs of the consumer, our research and development team believe we can produce biPAP equipment that can be small in size, travel friendly and also energy efficient.

  • GlobeNewswire7 months ago

    Management Changes at Rafina Innovations Inc.

    Glasgow, Scotland, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. (formerly HCi Viocare) (VICA), provides update on recent management changes.   Rafina Innovations Inc. was created to be a dynamic technology start-up.  Mr. Constantinos Zertalis has been appointed President and CEO of Rafina Innovations Inc. As we shift from company-creation to company-growth, Mr. Zertalis will provide the leadership the company needs for its next phase.